drugset / Trial / NCT00198107
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
Phase 3
Completed
81 enrolled
Indiana University
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will determine the effectiveness of aripiprazole and D-Cycloserine in treating symptoms associated with autism in children.
Timeline
- Start
- 2005-09
- Primary completion
- 2011-09
- Completion
- 2011-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 10 mg | — |
| Comparator | Aripiprazole | Other / unclassified | 15 mg | — |
| Comparator | Cycloserine | Small molecule | 25 mg | — |
| Comparator | Cycloserine | Small molecule | 200 mg | — |